Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease.

Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease.
复制标题

DOI:
10.1111/j.1365-2141.2009.08007.x
复制
发表时间:
2010-03
影响因子:
6.5
通讯作者:
Byrd JC
Byrd JC
中科院分区:
医学2区
文献类型:
--
作者:
Woyach JA;Heerema NA;Zhao J;McFaddin A;Stark A;Lin TS;Andritsos LA;Blum KA;Flynn JM;Jones JA;Byrd JC

文献摘要

参考文献

被引文献

相似文献

Interphase cytogenetics are commonly used to identify clonal abnormalities in chronic lymphocytic leukemia (CLL) patients but fail to identify recurrent translocations that ultimately can direct more focused molecular characterization. Given the importance of del(17p13.1) in CLL outcome, we performed an extensive review of 1213 patients undergoing metaphase cytogenetics at our institution and identified 16 (1.3%) with a recurrent unbalanced translocation between the p arms of chromosomes 17 and 18 that results in a dicentric chromosome with loss of much of 17p and 18p. The dic(17;18)(p11.2;p11.2) was associated with a complex (three or more unrelated cytogenetic abnormalities) karyotype in 12 patients (75%) at the time that the abnormality was first identified, and eventually associated with a complex karyotype in 94% of patients. IGHV mutational analysis was un-mutated in 88% of cases where evaluation was possible. Except for one patient who was diagnosed with CLL incidentally during a workup for metastatic tonsillar cancer, all patients identified with dic(17;18)(p11.2;p11.2) met criteria for disease treatment, with a median time from diagnosis to first treatment of 15 months. Our data demonstrate that dic(17;18)(p11.2;p11.2) is a novel recurrent cytogenetic abnormality in CLL associated with early age at diagnosis and accelerated disease progression. Future efforts to identify genes disrupted by this translocation are warranted and ongoing.
DOI: 10.1038/sj.leu.2404764
发表时间: 2007-08-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Van Den Neste, E.;Robin, V.;Michaux, L.
通讯作者: Michaux, L.
DOI: 10.1200/jco.2003.02.134
发表时间: 2003-11-01
影响因子: 45.3
作者:
Vasconcelos, Y;Davi, F;Dighiero, G
通讯作者: Dighiero, G
DOI: 10.1038/sj.leu.2401272
发表时间: 1999-03-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Callet-Bauchu, E;Salles, G;Felman, P
通讯作者: Felman, P
DOI: 10.1182/blood.v46.2.219.219
发表时间: 1975-01-01
期刊: BLOOD
影响因子: 20.3
作者:
RAI, KR;SAWITSKY, A;PASTERNACK, BS
通讯作者: PASTERNACK, BS
DOI: 10.1200/jco.2006.08.3089
发表时间: 2007-03-01
影响因子: 45.3
作者:
Grever, Michael R.;Lucas, David M.;Byrd, John C.
通讯作者: Byrd, John C.